Skip to main content

ArrayTrack: An FDA and Public Genomic Tool

  • Protocol
  • First Online:
Biological Networks and Pathway Analysis

Part of the book series: Methods in Molecular Biology ((MIMB,volume 1613))

Abstract

A robust bioinformatics capability is widely acknowledged as central to realizing the promises of toxicogenomics. Successful application of toxicogenomic approaches, such as DNA microarrays, inextricably relies on appropriate data management, the ability to extract knowledge from massive amounts of data and the availability of functional information for data interpretation. At the FDA’s National Center for Toxicological Research (NCTR), we are developing a public microarray data management and analysis software, called ArrayTrack that is also used in the routine review of genomic data submitted to the FDA. ArrayTrack stores a full range of information related to DNA microarrays and clinical and nonclinical studies as well as the digested data derived from proteomics and metabonomics experiments. In addition, ArrayTrack provides a rich collection of functional information about genes, proteins, and pathways drawn from various public biological databases for facilitating data interpretation. Many data analysis and visualization tools are available with ArrayTrack for individual platform data analysis, multiple omics data integration and integrated analysis of omics data with study data. Importantly, gene expression data, functional information, and analysis methods are fully integrated so that the data analysis and interpretation process is simplified and enhanced. Using ArrayTrack, users can select an analysis method from the ArrayTrack tool box, apply the method to selected microarray data and the analysis results can be directly linked to individual gene, pathway, and Gene Ontology analysis. ArrayTrack is publicly available online (http://www.fda.gov/nctr/science/centers/toxicoinformatics/ArrayTrack/index.htm), and the prospective user can also request a local installation version by contacting the authors.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

CDISC:

Clinical Data Interchange Standard Consortium

DEG:

Differentially Expressed Gene

FDA:

Food and Drug Administration

GO:

Gene Ontology

GOFFA:

Gene Ontology For Functional Analysis

HCA:

Hierarchical Cluster Analysis

IPA:

Ingenuity Pathway Analysis

KEGG:

Kyoto Encyclopedia of Genes and Genomes

MAQC:

MicroArray Quality Control

MIAME:

Minimum Information About a Microarray Experiment

NCTR:

National Center for Toxicological Research

PCA:

Principal Component Analysis

PGx:

Pharmacogenomics

SDTM:

Study Data Tabulation Model

TGx:

Toxicogenomics

VGDS:

Voluntary Genomic Data Submission

References

  1. Schmidt CW (2002) Toxicogenomics: an emerging discipline. Environ Health Perspect 110:A750–A755

    Article  PubMed  PubMed Central  Google Scholar 

  2. Afshari CA, Nuwaysir EF, Barrett JC (1999) Application of complementary DNA microarray technology to carcinogen identification, toxicology, and drug safety evaluation. Cancer Res 59:4759–4760

    CAS  PubMed  Google Scholar 

  3. Nuwaysir EF, Bittner M, Trent J, Barrett JC, Afshari CA (1999) Microarrays and toxicology: the advent of toxicogenomics. Mol Carcinog 24:153–159

    Article  CAS  PubMed  Google Scholar 

  4. Hamadeh HK, Amin RP, Paules RS, Afshari CA (2002) An overview of toxicogenomics. Curr Issues Mol Biol 4:45–56

    CAS  PubMed  Google Scholar 

  5. Tong W, Cao X, Harris S, Sun H, Fang H, Fuscoe J, Harris A, Hong H, Xie Q, Perkins R, Shi L, Casciano D (2003) ArrayTrack—supporting toxicogenomic research at the U.S. Food and Drug Administration National Center for Toxicological Research. Environ Health Perspect 111:1819–1826

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Frueh FW (2006) Impact of microarray data quality on genomic data submissions to the FDA. Nat Biotechnol 24:1105–1107

    Article  CAS  PubMed  Google Scholar 

  7. Shi L, Reid LH, Jones WD, Shippy R, Warrington JA, Baker SC, Collins PJ, de Longueville F, Kawasaki ES, Lee KY, Luo Y, Sun YA, Willey JC, Setterquist RA, Fischer GM, Tong W, Dragan YP, Dix DJ, Frueh FW, Goodsaid FM, Herman D, Jensen RV, Johnson CD, Lobenhofer EK, Puri RK, Schrf U, Thierry-Mieg J, Wang C, Wilson M, Wolber PK, Zhang L, Amur S, Bao W, Barbacioru CC, Lucas AB, Bertholet V, Boysen C, Bromley B, Brown D, Brunner A, Canales R, Cao XM, Cebula TA, Chen JJ, Cheng J, Chu TM, Chudin E, Corson J, Corton JC, Croner LJ, Davies C, Davison TS, Delenstarr G, Deng X, Dorris D, Eklund AC, Fan XH, Fang H, Fulmer-Smentek S, Fuscoe JC, Gallagher K, Ge W, Guo L, Guo X, Hager J, Haje PK, Han J, Han T, Harbottle HC, Harris SC, Hatchwell E, Hauser CA, Hester S, Hong H, Hurban P, Jackson SA, Ji H, Knight CR, Kuo WP, LeClerc JE, Levy S, Li QZ, Liu C, Liu Y, Lombardi MJ, Ma Y, Magnuson SR, Maqsodi B, McDaniel T, Mei N, Myklebost O, Ning B, Novoradovskaya N, Orr MS, Osborn TW, Papallo A, Patterson TA, Perkins RG, Peters EH, Peterson R, Philips KL, Pine PS, Pusztai L, Qian F, Ren H, Rosen M, Rosenzweig BA, Samaha RR, Schena M, Schroth GP, Shchegrova S, Smith DD, Staedtler F, Su Z, Sun H, Szallasi Z, Tezak Z, Thierry-Mieg D, Thompson KL, Tikhonova I, Turpaz Y, Vallanat B, Van C, Walker SJ, Wang SJ, Wang Y, Wolfinger R, Wong A, Wu J, Xiao C, Xie Q, Xu J, Yang W, Zhong S, Zong Y, Slikker W Jr (2006) The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements. Nat Biotechnol 24:1151–1161

    Article  CAS  Google Scholar 

  8. Guidance for Industry: Pharmacogenomic data submissions–Companion Guidance: Department of Health and Human Services (HHS), Food and Drug Administration (FDA) (August 2007) http://www.fda.gov/cder/guidance/7735dft.pdf

  9. Clinical Data Interchange Standard Consortium (CDISC): CDISC Inc., 15907 Two Rivers Cove, Austin, Texas 78717 (2007) http://www.cdisc.org/index.html

  10. Tong W, Harris S, Cao X, Fang H, Shi L, Sun H, Fuscoe J, Harris A, Hong H, Xie Q, Perkins R, Casciano D (2004) Development of public toxicogenomics software for microarray data management and analysis. Mutat Res 549:241–253

    Article  CAS  PubMed  Google Scholar 

  11. Brazma A, Hingamp P, Quackenbush J, Sherlock G, Spellman P, Stoeckert C, Aach J, Ansorge W, Ball CA, Causton HC, Gaasterland T, Glenisson P, Holstege FC, Kim IF, Markowitz V, Matese JC, Parkinson H, Robinson A, Sarkans U, Schulze-Kremer S, Stewart J, Taylor R, Vilo J, Vingron M (2001) Minimum Information About a Microarray Experiment (MIAME)-toward standards for microarray data. Nat Genet 29:365–371

    Article  CAS  PubMed  Google Scholar 

  12. Quackenbush J (2002) Microarray data normalization and transformation. Nat Genet 32(Suppl):496–501

    Article  CAS  PubMed  Google Scholar 

  13. Fielden MR, Halgren RG, Dere E, Zacharewski TR (2002) GP3: GenePix post-processing program for automated analysis of raw microarray data. Bioinformatics 18:771–773

    Article  CAS  PubMed  Google Scholar 

  14. Tusher VG, Tibshirani R, Chu G (2001) Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A 98:5116–5121

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Chen T, Guo L, Zhang L, Shi LM, Fang H, Sun YM, Fuscoe JC, Mei N (2006) Gene expression profiles distinguish the carcinogenic effects of aristolochic acid in target (kidney) and non-target (liver) tissues in rats. BMC Bioinformatics 7(Suppl 2):S20

    Article  PubMed  PubMed Central  Google Scholar 

  16. Sun H, Fang H, Chen T, Perkins R, Tong W (2006) GOFFA: Gene Ontology for Functional Analysis—a FDA Gene ontology tool for analysis of genomic and proteomic data. BMC Bioinformatics 7(Suppl 2):S23

    Article  PubMed Central  Google Scholar 

  17. Arlt VM, Ferluga D, Stiborova M, Pfohl-Leszkowicz A, Vukelic M, Ceovic S, Schmeiser HH, Cosyns JP (2002) Is aristolochic acid a risk factor for Balkan endemic nephropathy-associated urothelial cancer? Int J Cancer 101:500–502

    Article  CAS  PubMed  Google Scholar 

  18. Shav-Tal Y, Zipori D (2002) The role of activin a in regulation of hemopoiesis. Stem Cells 20:493–500

    Article  CAS  PubMed  Google Scholar 

  19. Fang H, Perkins R, Tong W (2007) Omics integrating systems using ArrayTrack and other bioinformatics tools. Am Drug Discov 2:49–52

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Weida Tong .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer Science+Business Media LLC

About this protocol

Cite this protocol

Fang, H. et al. (2017). ArrayTrack: An FDA and Public Genomic Tool. In: Tatarinova, T., Nikolsky, Y. (eds) Biological Networks and Pathway Analysis. Methods in Molecular Biology, vol 1613. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-7027-8_13

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-7027-8_13

  • Published:

  • Publisher Name: Humana Press, New York, NY

  • Print ISBN: 978-1-4939-7025-4

  • Online ISBN: 978-1-4939-7027-8

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics